Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →15
🟡 Moderate
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
11,933
Total Claims
$1.3M
Drug Cost
835
Beneficiaries
$1,501
Cost/Patient
Risk Score Breakdown 15/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
+53%
Opioid rate vs peers
3.4% vs 2.2% avg
+6%
Cost per patient vs peers
$1,501 vs $1,411 avg
+41%
Brand preference vs peers
15.0% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
3.4%
Opioid Rate
409
Opioid Claims
$7,242
Opioid Cost
7.6%
Long-Acting Rate
Brand vs Generic
Brand: 1,777 claims · $991K
Generic: 10,067 claims · $258K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 233 | $204K |
| Dulaglutide | 126 | $142K |
| Semaglutide | 87 | $103K |
| Rivaroxaban | 67 | $72K |
| Fluticasone/Umeclidin/Vilanter | 53 | $61K |
| Empagliflozin | 47 | $58K |
| Budesonide/Formoterol Fumarate | 65 | $26K |
| Insulin Glargine,hum.Rec.Anlog | 41 | $20K |
| Mirabegron | 27 | $18K |
| Insulin Detemir | 13 | $17K |
| Dronedarone Hcl | 13 | $17K |
| Rosuvastatin Calcium | 426 | $16K |
| Sacubitril/Valsartan | 11 | $15K |
| Insulin Lispro | 17 | $15K |
| Sitagliptin Phosphate | 25 | $13K |
Prescribing Profile
Patient Profile
75
Avg Age
73%
Female
1.02
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About